Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 30;13(9):2175-2186.
doi: 10.21037/tlcr-24-304. Epub 2024 Sep 12.

Diagnostic efficacy of cryobiopsy for peripheral pulmonary lesions with ground-glass opacity: a propensity score-matched analysis

Affiliations

Diagnostic efficacy of cryobiopsy for peripheral pulmonary lesions with ground-glass opacity: a propensity score-matched analysis

Hideaki Furuse et al. Transl Lung Cancer Res. .

Abstract

Background: Peripheral pulmonary lesions (PPLs) with ground-glass opacity (GGO) are generally difficult to diagnose via bronchoscopy. Cryobiopsy, a recently introduced technique, provides quantitatively and qualitatively superior tissues compared with conventional biopsy methods and can improve diagnostic outcomes. However, its diagnostic accuracy has not been specifically investigated. Therefore, this study aimed to determine whether the combined use of cryobiopsy improves the diagnostic yield for PPLs with GGO.

Methods: Consecutive patients who underwent bronchoscopy combined with radial endobronchial ultrasound and virtual bronchoscopic navigation for PPLs with GGO were retrospectively reviewed between June 2014 and May 2020. Cryobiopsy was introduced at our institution in June 2017. Patients who underwent only conventional biopsy (forceps and/or needle aspiration) between June 2014 and May 2017 were classified as the conventional group, whereas those who underwent cryobiopsy with or without conventional biopsy between June 2017 and May 2020 were categorized as the "cryo" group. The diagnostic performance of the two groups was compared using propensity score-matched analysis.

Results: Overall, 553 cases were identified, including 250 and 303 in the cryo and conventional groups, respectively. Propensity scoring was implemented to match lesion characteristics and intraprocedural findings, leading to the selection of 232 pairs of cases for each matched (m) group. The diagnostic yield in the m-cryo group was significantly higher than that in the m-conventional group [88.8% vs. 63.8%, odds ratio: 4.50 (95% confidence interval: 2.76-7.33), P<0.001]. Although the incidence of grade 2 and 3 bleeding in the m-cryo group was higher than that in the m-conventional group (40.5% vs. 8.6% and 2.6% vs. 0.4%, respectively; P<0.001), grade 4 bleeding was not reported.

Conclusions: The combined use of cryobiopsy provides improved diagnostic yield for PPLs with GGO compared with conventional biopsy methods.

Keywords: Bronchoscopy; cryobiopsy; ground-glass opacity (GGO); peripheral pulmonary lesion (PPL).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tlcr.amegroups.com/article/view/10.21037/tlcr-24-304/coif). H.F. receives lecture fees from Erbe Elektromedizin GmbH and AstraZeneca. Y.M. receives a research funds from Hitachi; consulting fees from INTUITIVE; and lecture fees from Olympus, AstraZeneca, Novartis, COOK, AMCO, Thermo Fisher Scientific, Erbe Elektromedizin GmbH, Fujifilm, Chugai, Eli Lilly, Merck, Takeda, and ETHICON. K.U. receives grants from Japan Society for the Promotion of Science (JSPS) KAKENHI (Grant Number JP22K15698 and JP19K16966) and lecture fees from Novartis, Thermo Fisher Scientific, AstraZeneca, and Chugai. T.I. receives a research funds from Hitachi High-Tech Corporation and lecture fees from COOK, Chugai Pharma, Eli Lilly, Thermo Fisher Scientific K.K., Olympus, Novartis Pharma, and Fujifilm. The other authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Flow diagram of patient selection. GGO, ground-glass opacity; PPL, peripheral pulmonary lesion; VBN, virtual bronchoscopic navigation.
Figure 2
Figure 2
A representative case of a 69-year-old woman who could be diagnosed only with a specimen collected via cryobiopsy. (A) High-resolution CT shows a 22.5-mm part-solid nodule (arrow) in the right upper lobe with a positive bronchus sign. (B) Cryobiopsy was performed at the location where radial endobronchial ultrasound detected the lesion, which exhibited a blizzard sign (bottom right corner). (C) The specimen is 4.3 mm × 3.5 mm in size without noticeable crush artifacts (hematoxylin and eosin stain, ×1.2 magnification). (D) At higher magnification (square), tumor cells forming a lepidic growth pattern were clearly observed, leading to a diagnosis of adenocarcinoma (hematoxylin and eosin stain, ×10 magnification). CT, computed tomography.

References

    1. Yankelevitz DF, Yip R, Smith JP, et al. CT Screening for Lung Cancer: Nonsolid Nodules in Baseline and Annual Repeat Rounds. Radiology 2015;277:555-64. 10.1148/radiol.2015142554 - DOI - PMC - PubMed
    1. Goo JM, Park CM, Lee HJ. Ground-glass nodules on chest CT as imaging biomarkers in the management of lung adenocarcinoma. AJR Am J Roentgenol 2011;196:533-43. 10.2214/AJR.10.5813 - DOI - PubMed
    1. Kakinuma R, Noguchi M, Ashizawa K, et al. Natural History of Pulmonary Subsolid Nodules: A Prospective Multicenter Study. J Thorac Oncol 2016;11:1012-28. 10.1016/j.jtho.2016.04.006 - DOI - PubMed
    1. Kim BT, Kim Y, Lee KS, et al. Localized form of bronchioloalveolar carcinoma: FDG PET findings. AJR Am J Roentgenol 1998;170:935-9. 10.2214/ajr.170.4.9530038 - DOI - PubMed
    1. Kurimoto N, Miyazawa T, Okimasa S, et al. Endobronchial ultrasonography using a guide sheath increases the ability to diagnose peripheral pulmonary lesions endoscopically. Chest 2004;126:959-65. 10.1378/chest.126.3.959 - DOI - PubMed